Jan Fohlman
About
In The Last Decade
Jan Fohlman
77 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 130
- Molecular Biology 915
- Genetics 863
- Cardiology and Cardiovascular Medicine 588
- Immunology 350
- Spectroscopy 324
Countries citing papers authored by Jan Fohlman
This map shows the geographic impact of Jan Fohlman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Fohlman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Fohlman more than expected).
Fields of papers citing papers by Jan Fohlman
This network shows the impact of papers produced by Jan Fohlman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Fohlman. The network helps show where Jan Fohlman may publish in the future.
Co-authorship network of co-authors of Jan Fohlman
This figure shows the co-authorship network connecting the top 25 collaborators of Jan Fohlman. A scholar is included among the top collaborators of Jan Fohlman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Fohlman. Jan Fohlman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 50 | |
| 3 | Mikrobiell diagnostik med PCR blir kliniskt värdefull när analystiden kortas [Microbial diagnosis with PCR will become clinically beneficial with a faster analysis] | 0 |
| 4 | 58 | |
| 5 | 16 | |
| 6 | 3 | |
| 7 | 26 | |
| 8 | 45 | |
| 9 | 92 | |
| 10 | 22 | |
| 11 | 4 | |
| 12 | 27 | |
| 13 | 18 | |
| 14 | High yield production of an inactivated coxsackie B3 adjuvant vaccine with protective effect against experimental myocarditis. | 35 |
| 15 | 21 | |
| 16 | 17 | |
| 17 | 62 | |
| 18 | 60 | |
| 19 | 18 | |
| 20 | 123 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.